The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

My own experience initially led me to believe that weight loss was just a matter of commitment and a modicum of self-control.

Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But ...

As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

The report shows a rise in medication use, obesity, and smoking, a decline in cancer screenings, concerns over excessive ...

An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of ...

This led to a new off-label use of semaglutide as a weight-loss aid, and in 2021, the FDA approved a higher dose of the drug, ...

Alaunos Therapeutics is axing an agreement with Precigen, giving up licensing rights to a personalized T-cell platform. | ...